ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Elevated systemic immune inflammation level increases the risk of total and cause-specific mortality among patients with chronic kidney disease: a large multi-center longitudinal study

Lai, Wenguang; Xie, Yun; Zhao, Xiaoli; Xu, Xiayan; Yu, Sijia; Lu, Hongyu; Huang, Haozhang; Li, Qiang; Xu, Jun-Yan; Liu, Jin*; Chen, Shiqun*; Liu, Yong*广东省人民医院; 广东省心血管病研究所; 南方医科大学; 海南医学院; 中山大学; y
Inflammation Research2023-1DOI: 10.1007/s00011-022-01659-y
7被引6阅读
引用收藏
分享

摘要

Background Chronic kidney disease (CKD) is inherently a complex immune-inflammatory condition, and heightened inflammation and immune dysfunction are closely related to an increased risk of death. However, evidence regarding the relationship between immune-inflammatory levels and all-cause, cardiovascular, and cancer mortality among patients with CKD is scarce. Methods Patients with non-dialysis dependent CKD undergoing coronary angiography (CAG) were included from five Chinese tertiary hospitals. Systemic immune inflammation index (SII) was calculated by multiplying peripheral platelet count with neutrophil-to-lymphocyte ratio, and patients were categorized into four groups by SII quartiles. Cox regression models and competing risk Fine and Gray models were used to examining the relationships between SII levels and all-cause, cardiovascular, and cancer mortality. Results A total of the 19,327 patients (68.8 +/- 10.03 years, female 32.0%) were included in this study. During a median follow-up of 4.5 years, 5,174 deaths occurred, including 2,861 cardiovascular deaths and 375 cancer deaths. Controlling for confounders, all-cause mortality (Q2, Q3, Q4: hazard ratio(HR) [95 CI%] = 1.15 [1.06-1.26], 1.30 [1.19-1.42], 1.48 [1.35-1.62], respectively; p for trend < 0.001) and cardiovascular mortality (Q2, Q3, Q4: HR [95 CI%] = 1.16 [1.03-1.31], 1.40 [1.24-1.58], 1.64 [1.44-1.85], respectively; p for trend < 0.001) increased with higher SII levels, and SII levels was related to cancer mortality comparing last quartile to first quartile of SII (Q2, Q3, Q4: HR [95 CI%] = 1.12 [0.83-1.52], 1.22 [0.90-1.67], 1.50 [1.09-2.08], respectively; p for trend < 0.001). Conclusion Elevated immune inflammation level on admission was an independent risk factor for all-cause, cardiovascular, and cancer mortality among CKD patients. Further research is needed to validate the predictive value of SII for mortality risk among CKD patients.

学科与关键词

关键词
Systemic immune inflammation indexChronic kidney diseaseAll-cause mortalityCardiovascular mortalityCancer mortality
相关
加载中…
  • Association of systemic immune-inflammation index and systemic inflammation response index with chronic kidney disease: observational study of 40,937 adults
    Huang, Peixian; Mai, Yanpei*; Zhao, Jun; Yi, Yushan; Wen, YaqingInflammation Research, 2024, 73(4): 655-667.
  • Elevation of Preprocedural Systemic Immune Inflammation Level Increases the Risk of Contrast-Associated Acute Kidney Injury Following Coronary Angiography: A Multicenter Cohort Study
    Lai, Wenguang; Zhao, Xiaoli; Huang, Zhidong; Xie, Yun; Yu, Sijia; Tu, Jiabin; Guo, Dachuan; Xiu, Jiaming; Mai, Ziling; Li, Qiang; Huang, Haozhang; Li, Huanqiang; Xu, Jun-Yan; Lu, Hongyu; Chen, Guanzhong; Chen, Shiqun; Liu, Jin*; Liu, Yong*Journal of Inflammation Research, 2022, 15: 2959-2969.被引 3
  • Association Between Systemic Immune Inflammation Level and Poor Prognosis Across Different Glucose Metabolism Status in Coronary Artery Disease Patients
    Xu, Xiayan; Xie, Yun; Gu, Xia; Zhou, Yang; Kang, Yu; Liu, Jin; Lai, Wenguang; Lu, Hongyu; Chen, Shiqun; Xu, Jun-yan; Lin, Feng*; Liu, Yong*Journal of Inflammation Research, 2023, 16: 4031-4042.
查看全部 →

发表信息

论文状态
公开发表
期刊
Inflammation Research
发表日期
2023-01
卷期
第 72 卷, 第 1 期
页码
149-158
DOI
10.1007/s00011-022-01659-y
语言
ENGLISH
成果收录
SCIE
资助标注
Beijing Lisheng Cardiovascular Health Foundation Pilot Fund [LHJJ20141751]; National Science Foundation of China [81970311, 82070360]; Clinical Medicine Research Fund of Guangdong Province [2019ZX01]; Key Laboratory of Emergency and Trauma (Hainan Medical University), Ministry of Education [KLET-202116]; NSFC Incubation Project of Guangdong Provincial People Hospital [KY0120220041]

作者

  • L

    Lai, Wenguang (第一作者)

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • X

    Xie, Yun

    guangdong cardiovasc inst · guangdong prov peoples hosp

查看全部 12 位作者收起作者
  • Z

    Zhao, Xiaoli

    sun yat sen univ

  • X

    Xu, Xiayan

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • Y

    Yu, Sijia

    guangdong cardiovasc inst · guangdong prov peoples hosp · 2 · southern med univ

  • L

    Lu, Hongyu

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • H

    Huang, Haozhang

    guangdong cardiovasc inst · guangdong prov peoples hosp · 2 · southern med univ

  • L

    Li, Qiang

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • X

    Xu, Jun-Yan

    guangdong cardiovasc inst · guangdong prov peoples hosp · hainan med univ

  • L

    Liu, Jin (通讯)

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • C

    Chen, Shiqun (通讯)

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • L

    Liu, Yong (通讯)

    guangdong cardiovasc inst · guangdong prov peoples hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417